IDHC.LSE Integrated Diagnostics Holdings PLC

Healthcare Health Care Providers & Services London Exchange
0.4610 USD
Close of Nov 3, 2026
0.4500 0.8222
Market cap
USD 268M
P/E
9.2x
P/B
3.73x
ROE
41.9%
Dividend yield
1.85%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is IDHC.LSE undervalued?

Graham number
Price0.4610
Graham value0.3727
Premium23.7%

IDHC.LSE trades 23.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Integrated Diagnostics Holdings PLC fundamental analysis

No fundamental analysis for Integrated Diagnostics Holdings PLC yet.

Integrated Diagnostics Holdings PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Integrated Diagnostics Holdings PLC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography…

Full company profile